• FirefoxInstall the new Firefox »
  •  Dow Down0.23% Nasdaq Down0.27%

    SciClone Pharmaceuticals, Inc. (SCLN)

    -NasdaqGS
    8.54 Up 0.22(2.64%) Mar 26, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 134,790   127,058   156,269  
    Cost of Revenue23,002  17,668  21,996  
    Gross Profit 111,788   109,390   134,273  
    Operating Expenses
    Research Development14,581  8,044  5,145  
    Selling General and Administrative71,223  89,736  76,249  
    Non Recurring -  1,181  43,824  
    Others -   -  2,645  
    Total Operating Expenses -   -  127,863  
    Operating Income or Loss 25,984   10,429   6,410  
    Income from Continuing Operations
    Total Other Income/Expenses Net441  2,880  47  
    Earnings Before Interest And Taxes26,425  13,309  6,457  
    Interest Expense48  103  185  
    Income Before Tax26,377  13,206  6,272  
    Income Tax Expense1,169  2,242  (3,348)
    Minority Interest -   -   -  
    Net Income From Continuing Ops25,208  10,964  9,620  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 25,208   10,964   9,620  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 25,208   10,964   9,620  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.